Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Upadacitinib effectively treats pyoderma gangrenosum.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

PAR-1 may play a role in hair growth regulation in human hair follicles.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Blocking mTORC1 reduces skin tumor growth in mice.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Vibration treatment may reduce migraine pain by changing cell structures.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

ITK inhibitors may effectively treat alopecia areata.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.